Health
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket in popularity over the last year — is now approved in the U.S. for heart health, too. But that may not translate to wider insurance coverage of […]
Read More
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen. Rafael Henrique | SOPA Images | Lightrocket | Getty Images The Food and Drug Administration on Thursday approved the first-ever treatment for a common and potentially deadly form of liver disease that affects millions worldwide. The FDA’s decision means Madrigal Pharmaceuticals […]
Read More
WeightWatchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
Sima Sistani, CEO, WW International, August 16, 2023. Scott Mlyn | CNBC WeightWatchers CEO Sima Sistani has sent an internal memo to employees attempting to reassure them that the financial position of the company is solid and its new clinical business related to the threat of GLP-1 weight loss drugs is growing faster than expected. […]
Read More
A firm that serves kids with autism grew until it had 265 clinics. Then private equity took over.
Misty Richard and her son, Javier “J.J.” Bautista. NBC News Like many parents of autistic children, Misty Richard was thrilled in 2017 to find a clinic close to her home in Baton Rouge, Louisiana, that could help her son, Javier Bautista, known as J.J. The facility was operated by the Center for Autism and Related Disorders, a […]
Read More
Experts hesitate on weight loss ETFs amid the obesity drug boom
There may be a stronger case to invest in single stocks over exchange-traded funds in the weight loss space. Amplify ETFs and Roundhill Investments each filed a prospectus last week to launch funds focused on weight loss companies, a move that Strategas ETF and technical strategist Todd Sohn believes hinges on the performance of two […]
Read More
Biden administration investigating Change Healthcare cyberattack as disruptions continue
In this photo illustration, the UnitedHealth Group logo is displayed on a tablet. Igor Golovniov | Sopa Images | Lightrocket | Getty Images The U.S. Department of Health and Human Services has launched an investigation into UnitedHealth Group following the cyberattack on its Change Healthcare unit that has disrupted crucial operations in pharmacies and hospitals […]
Read More
The news hitting a portfolio health-care name actually removes an overhang on the stock
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. U.S. stocks were mixed Wednesday following Tuesday’s record high close for the S & P 500 on a rebound in the artificial intelligence momentum trade. One day later, tech was […]
Read More
Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! The bitter legal battle […]
Read More
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021. Smith Collection | Gado | Getty Images Eli Lilly on Wednesday said Amazon Pharmacy will help send certain prescription drugs, including the red-hot weight loss treatment Zepbound, to patients’ homes through the drugmaker’s new direct-to-consumer program. Starting Wednesday, […]
Read More
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
Nurphoto | Nurphoto | Getty Images Pfizer is ready to move on from Covid. Now, the company is betting on cancer drugs to help it regain its footing after a rocky year marked by the rapid decline of its Covid business. It just might take a while before that bet pays off. Pfizer pitched its […]
Read More